Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson May 22, 2020 10:36am
125 Views
Post# 31060608

RE:RE:RE:RE:Take a look at “MIR”

RE:RE:RE:RE:Take a look at “MIR”

Are they? If they are, wouldn't the SP be a lot more than 0.10. Is Aristotle all that we think it is? Honestly, ask yourself this... if this company was on the edge of a worldwide breakthrough, wouldn't you have major investors investing in it? You have Kevin O'Leary purchasing psychedelic venture plays. Why aren't big names/money scooping this up? I'm tired of JHT's claims. If anyone remembers the Q3 conference call, StageZero was supposed to be claiming $1,000's in revenue. Yet, $50,000 from the quarter, burning through $3,000,000. So please, why should anyone in their right mind think that this is moon bound?


skier59 wrote: Ya and we are about to launch the best damn CANCER TEST in the WORLD !

 

LithLover wrote: MIR did $90,000 in revenue continues to lose money and has a market cap of $250 million.  SZLS getting bashed for only doing $50,000 in revenue despite adding covid partners and has a market cap of $30 million.    
skier59 wrote: What an idiot skyhawk1, comes on the board and says he dumped SZLS and basically calls it a P&D on other boards. Then he comes here and promotes a real P&D that had a SP range bound for 10 years between 1 and 3 cents and last month went up well over 1000% and tells everybody to join him. Once COVID-19 is done, so is MIR back to 2 cents with their 700 million shares.

 




Bullboard Posts